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Abstract
The widespread use of antibiotics in food animal production systems has
resulted in the emergence of antibiotic resistant zoonotic bacteria that can be
transmitted to humans through the food chain. Infection with antibiotic
resistant bacteria negatively impacts on public health, due to an increased
incidence of treatment failure and severity of disease. Development of
resistant bacteria in food animals can result from chromosomal mutations but
is more commonly associated with the horizontal transfer of resistance
determinants borne on mobile genetic elements. Food may represent a
dynamic environment for the continuing transfer of antibiotic resistance
determinants between bacteria. Current food preservation systems that use a
combination of environmental stresses to reduce growth of bacteria, may
serve to escalate development and dissemination of antibiotic resistance
among food related pathogens. The increasing reliance on biocides for
pathogen control in food production and processing heightens the risk of
selection of biocide-resistant strains. Of particular concern is the potential for
sublethal exposure to biocides to select for bacteria with enhanced multi-drug
efflux pump activity capable of providing both resistance to biocides and
cross-resistance to multiple antibiotics. Although present evidence suggests
that biocide resistance is associated with a fitness physiological costs, the
possibility of the development of adaptive mutations conferring increased
fitness cannot be out-ruled. Strategies aimed at inhibiting efflux pumps and
eliminating plasmids could help to restore therapeutic efficacy to antibiotics
and reduce the spread of antibiotic resistant food borne pathogens through
the food chain.
2

1. Introduction
Over the last two decades there has been an increase in the number of
antibiotic resistant bacteria isolated from humans and animals. The overuse
and misuse of antibiotics in both human and veterinary medicine has
contributed to this global pandemic of antibiotic resistant bacteria [1]. In
contrast to human medicine, antibiotics are used therapeutically,
prophylactically and sub-therapeutically as growth promoters in food animals
[2]. This has led to the development of resistance to antibiotics in foodborne
pathogens which can ultimately be transmitted to humans via the food chain
[3,4]. Although most cases of foodborne disease result in self-limiting
diarrhoea, antibiotic therapy is warranted in cases of persistent enteritis,
bacteraemia and in immunocomprised individuals. Infection with antibiotic
resistant bacteria can complicate initial treatment and result in prolonged
duration of illness, an enhanced risk of mortality or invasive illness and
increased healthcare costs. The Centers for Disease Control and Prevention
estimate that foodborne diseases are responsible for about 76 million
illnesses, resulting in 325,000 hospitalisations and 5,000 deaths in the United
States each year [5].
Antibiotic resistance typically occurs as a result of target gene mutation, drug
inactivation and decreased accumulation resulting from decreased
permeability and /or increased efflux [6]. The horizontal transfer of resistance
determinants on mobile genetic elements such as plasmids, transposons and
integrons, promotes the rapid spread of antimicrobial resistance genes
between different species and genera of bacteria and the development of a
multi-drug resistance phenotype. More recently, considerable attention has
3

focussed on the role of multi-drug efflux pumps in mediating multi-resistance
[7].
In response to the concern about the growing impact of antibiotic resistance in
clinical practice, European Union (EU) regulations have banned the use of
antibiotic growth promoters in animal feed [8]. Consumer demands for safe
food has resulted in an increase in biosecurity measures in the food
production industry, including the use of biocides to control and reduce
microbial communities associated with food spoilage and disease [9].
Additionally, the increased public awareness of hygiene has resulted in a
deluge of consumer healthcare and cleaning products touting antimicrobial
uses [10]. Increased exposure to biocides has contributed to the emergence
of pathogens showing decreased suceptibility to them. Resistance to biocides
may be due to target gene mutations [11, 12], however, it is more commonly
associated with increased efflux pump activity [13,14,15]. As antibiotics are
substrates for these pumps, also this also raises the concern that biocides
can select for multi-drug resistance in clinically important bacteria in the
absence of antibiotic selective pressure [16].

This review examines the contribution of stresses encountered in the food
processing environment to the emergence and spread of antibiotic resistance.
Consideration is given to the use of biocides by the food industry and the
emergence of resistance to these agents. Mechanisms associated with
biocide resistance and the potential for biocides to select for antibiotic
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resistant bacterial are explored. Finally, the fitness physiological cost of
biocide resistance is examinedexplored.

2. Horizontal transfer of antibiotic resistance
Although chromosomal mutations can be responsible for the development of
antibiotic resistance [17], mutation occurs at a relatively low frequency of one
per 1 billion cell divisions [18]. Consequently, transferable resistance poses a
greater threat as it can achieve much larger dimensions owing to widespread
rapid dissemination among bacteria of different taxonomic and ecological
groups [18]. Genetic exchange can occur by conjugation (plasmid-mediated),
transduction (bacteriophage-mediated) or transformation (which may involve
plasmids and naked DNA). Conjugation is the most frequently recognised
mechanism for horizontal gene transfer. Plasmids may contain particular
genetic structures including composite and/or complex transposons, known as
“jumping genes” along with the more recently described integron structures
(Figure 1), which can increase the rate of dissemination of resistance genes
between bacteria. Integrons can capture antibiotic resistance encoding genes
via site-specific recombination [19, 20]. These integrons possess a conserved
structure on the proximal end (known as the 5’-CS) containing an integrase
gene (intI), a recombination site (attl) and a promoter (Pant), along with a
conserved distal region (3’-CS) containing a qacE1 [conferring resistance
to quaternary ammonium compound(s) (QAC’s)] and a sul1 determinant
(conferring resistance to sulphonamide). These CS regions flank a variable
central locus, into which gene cassettes are recombined, composed of one or
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more open reading frames (ORF) encoding antibiotic resistance gene(s) [21].
More then 60 different gene cassettes have been identified, with some
integrons possessing multiple gene cassettes arranged in a classical ‘head-totail’ orientation [22]. As these resistance determinants are under the control
of a single strong upstream promoter (located towards the 3’ end of intI), all
recombined gene cassettes are co-expressed. Therefore, selective pressure
imposed by the use of a particular antibiotic, can co-select for another
resistance determinant located within an adjacent gene cassette [23].
Additionally, exposing integron-containing bacteria to sub-inhibitory levels of
QACs may co-select for antibiotic resistance [24].

2.1 Antibiotic resistance transfer in food and the effect of food
preservation stresses
Gene transfer has been shown to occur in a variety of complex media
including the gut of various animals [25], the human colon [26], cultured
human cells [27], bovine rumen fluid [28], sewage [29], surface water [30] and
calf faeces [31]. Several studies to-date have successfully demonstrated
laboratory-based gene transfer by conjugation with food-borne bacterial
strains in broth (liquid mating) [32, 33, 34] or by filter (solid surface) mating
[35, 36]. However, there is limited data describing gene transfer in the in situ
food matrix [37].
Walsh et al. (2008) reported the transfer of an ampicillin resistance marker via
a R-plasmid from S. Typhimurium DT104 to a susceptible recipient E. coli K12
in broth, milk and ground meat, at 25 and 37oC within 24 h. A higher rate of
6

transfer (10-2 cfu/g transconjugants per recipient) was reported in ground
meat at 48 h [38]. Similarly, Van der Auwera et al. (2007) reported plasmid
transfer (at 10-1 cfu ml/g transconjugants per recipient) for Bacillus
thuringiensis in broth, milk and milk pudding [39]. Cocconelli et al. (2003),
reported the transfer of a vancomycin resistance gene via a conjugative Rplasmid in enterococcal strains during cheese and sausage fermentation [37].
These authors reported a 2-3 log (cfu/g) increase in the transfer rate of
plasmids in meat, and suggested that factors including plasma in the meat
matrix could play an important role in increasing the rate of plasmid transfer
[40].
Recent evidence suggests that plasmid transfer may also be more rapid
between bacteria in minimally processed foods, held under sub-lethal food
preservation stresses such as high/low temperature, osmotic and pH stress.
Using experimental broth/filter mating conditions, McMahon et al., (2007)
reported significantly increased rates of antibiotic resistance plasmid transfer
between E. coli strains and E. coli and S. Typhimurium strains held under the
typical environmental food preservation stresses used by the food industry
[41]. However, it was not determined whether this was due to increased
donor plasmid transfer or more efficient plasmid capture by the recipient. On a
positive note, biocides have been show to reduce the rates of plasmid transfer
(by both conjugation and transduction) [68]

3. Biocides and their use in food production
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Biocides refer to a broad category of agents including sanitizers, disinfectants
and food preservatives [24] (see Figure 2-which provides a general summary
of this classification). For the purposes of this review we will confine our
discussion to the first two listed categories. Biocides which include
disinfectants and sanitizers can be further differentiated based on the
organism(s) they target and directions for use [42]. A disinfectant must
completely eliminate all the organisms against which it is directed, whilst a
sanitizer need not eliminate all of the organisms that it is targeted against. The
efficacy of biocides and the types of organisms that they inhibit vary
considerably, and is dependent on the compositional concentration and
synergism among the components [43]. Compared to antibiotics, the mode of
action of biocides is relatively non-specific. They damage cytoplasmic
membranes and can react unspecifically with functional groups of proteins or
nucleic acids [44].
Biocides are used as part of the biosecurity measures in livestock production
to prevent outbreaks and spread of disease and to decontaminate animal
housings. In the food processing environment they are used to prevent
product contamination with pathogens. Commonly used biocides for
environmental and surface cleaning include, quaternary ammonium
compounds (QAC’s), oxidising compounds, acid anionics, hypochlorite and
chlorine dioxide. Triclosan and chlorhexidine are used extensively in
handcare products [45]. Unusually unlike the approval process for antibiotics,
a risk assessment of the development of biocide resistance is not considered
during the approval of biocides for food industry use.
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3.1. Mechanisms associated with decreased susceptibility to biocides
It was considered highly unlikely that resistance to biocides would ever occur,
as most biocides are complexes of antimicrobial agents that act in unison to
inactivate multiple cellular targets [46,47]. However, reduced susceptibility to
biocides was first reported a century ago [48] and our current high
dependance on biocides, has resulted in some reports of reduced bacterial
susceptibility [49-53]. While reduced susceptibility to biocides does not
necessarily correlate with product failure, the implication of ineffective
pathogen control may be damaging to the food industry. Factors reducing the
effectiveness of biocides include the presence of organic material and biofilm
growth. Inadequate disinfection procedures in livestock production facilities
and food processing plants may contribute to the selection of biocide resistant
isolates as a result of exposure to sublethal biocide concentrations.
Staphylococci showing decreased susceptibility to QACs have been isolated
from food processing plants (54, 55). Langsrud and Sundheim (1997)
reported that more than 30% of Pseudomonas spp. isolated from poultry
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carcasses could grow in the presence of benzalklonium chloride at
concentrations used in the poultry plant (56). Resistance to QACs has been
demonstrated in Listeria spp. isolated from poultry products, red meat and
cheese [57]. In contrast a recent report showed that biocide resistance was
not a contributing factor to the persistence of strains of L. monocytogenes and
E. coli in the products and environment of five chilled food production facilities
(58). Although little is known about the effects of low concentrations of
biocides on bacterial biofilms, of potential significant to the food industry is
9
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the results of in-vitro studies showing that incomplete elimination of a biofilm
might lead to increased resistance after biofilm growth possibly due to the
selection of highly resistant clones. [59, 60]
Mechanisms of aquired antibiotic resistance have been widely studied and
clearly elucidated [19,20]. Comparatively, mechanisms of acquired biocide
resistance have been poorly evaluated. Biocide resistance can result from
mutation or from acquisition of resistance determinants on plasmids [54].
Resistance resulting from biocide inactivation is rare but has been
documentated for organomercurials [61,62]. Resistance can also result from
changes in cell permeability but is more often associated with enhanced
biocide efflux [61].
A number of efflux transporters capable of effluxing a single substrate, or a
wide variety of structurally unrelated agents including antibiotics and biocides,
have been identified in bacteria. The contribution of these efflux pumps to
antibiotic resistance is well documented and has been the subject of
numerous reviews [63-66]. Bacterial efflux systems are classified into five
families: the major facilitator (MF) superfamily, the ATP (adenosine
triphosphate)-binding cassette (ABC), the resistance nodulation-division
(RND) family, the small multi-drug resistance (SMR) family (a member of the
much larger drug/metabolite transporter (DMT) superfamily), and the multidrug and toxic compound extrusion (MATE) family [67]. Of these, MF
transporters are the most prevalent in Gram-positive bacteria [Figure 3 (a)]
and the RND transporters are the most common in Gram-negative bacteria
[(see Figure 3 (b)]). RND efflux pumps are organised as tripartite structures
consisting of an inner membrane pump, an outer membrane protein and a
10

periplasmic linker protein. Multi-drug efflux pumps such as RND pumps, are
generally chromosomally encoded, and their over-expression can result from
mutations in local or global regulators. This contrasts with drug-specific efflux
pumps, which are more usually encoded by mobile genetic elements [67] and
are single component structures [68].
Here we will review the mechanisms of resistance associated with some of
the commonly used biocides, namely; triclosan, quaternary ammonium
compounds (QAC's) and chlorhexidine [47,66] (see Figure 4- for chemical
structure).
Triclosan
Triclosan works specifically on enoyl-acyl reductase, an enzyme which is
essential for fatty acid synthesis. Modification, repression or deletion of the
specific cellular target fabI (encoding enoyl-acyl reductase) results in reduced
bacterial susceptibility to triclosan [11,12,68]. Triclosan has been reported to
target the FabI enzyme of a number of bacteria including spoilage organisms
such as P. aeruginosa and food pathogens such as E. coli, Salmonella and
Campylobacter. Characterisation of triclosan resistant mutants, revealed a
single-amino-acid change in fabI in the codon for glycine 93 in E. coli and
glycine 95 in P.aeruginosa (68). Additionally, many of the RND family pumps
associated with resistance to clinically important antibiotics are able to
accomodate triclosan. These include the AcrAB-TolC pump of E. coli [15] and
Salmonella [69], the CmeABC and CmeDEF of C. jejuni [70], and several of
the Mex pumps in P. aeruginosa [71].
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Quaternary ammonium compounds
Quaternary ammonium compounds (QAC e.g. benzalkonium chloride) act by
physical disruption and partial solubilisation of the cell and membrane. A
variety of plasmid and chromosomally encoded efflux determinants of QAC
resistance have been described in both Gram-negative and positive bacteria
[68]. Transporters capable of accomodating QACs in Gram-negative bacteria
are generally chromosomally encoded and include a number of MATE
(PmpM in P.aeruginosa), RND (AcrAB-TolC, AcrEF-TolC and YhiUV-TolC
pumps of E. coli), [64] and SMR family (EmrE in E. coli) [72] multi-drug
transporters. The SMR transporters, QacE and QacE1, QacF and QacG
found in Gram-negative bacteria are plasmid-encoded [73,64]. Interestingly,
as stated earlier the qacE1 is contained on the conserved distal region (3’CS) of a class 1 integron structure (Figure 1c). The chromosomal efflux
determinants of QAC resistance in Gram-positive bacteria include the MF
family NorA multi-drug transporter (usually associated with fluoroquinolone
resistance), the MF family MdeA and the MATE family MepA in S. aureus [74,
75, 76). In contrast to Gram-negative bacteria, the main mechanism of QAC
resistance in Gram-positive bacteria is plasmid-borne efflux, due to the SMR
family transporters QacC/D and QacE1, QacG, QacH and QacJ and the MF
family QacA/B transporter [64].
Chlorhexidine
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Bactericidal concentrations of chlorhexidine result in a denaturation of
cytoplasmic proteins and coagulation of the cell contents. The specific
12

mechanism(s) associated with chlorhexidine resistance still remain to be
elucidated. However, chlorhexidine resistance has been associated with
cepA, encoding a putative efflux mechanism in K. pneumoniae [77]. Indirect
evidence for the role of RND family exporters in chlorhexidine resistance has
been provided. Benzalkonium chloride and triclosan adapted E. coli displayed
a multi-drug-resistance phenotype including reduced susceptibility to
chlorhexidine, consistent with increased expression of an RND multi-drug
transporter [78]. Chlorhexidine has been shown to induce expression of the
MexCD-OprJ efflux pump in P. aeruginosa, although a role in chlorhexidine
resistance was not examined [79]. QacA/B in Gram-positive bacteria reduces
susceptibility to chlorhexidine [64, 79]
3.2 Links between biocide and antibiotic resistance
The link between biocide and antibiotic resistance has mainly been studied in
the laboratory by selecting bacteria with decreased susceptibility to biocides.
Numerous studies have clearly demonstrated that selection for biocide
resistance can result in cross-resistance to antibiotics [80-83]. Furthermore,
several studies have unequivocally demonstrated that selection for multiple
antibiotic resistance results from increased expression of multi-drug
transporters capable of accommodating both biocides and antibiotics [9, 15,
16, 71, 84, 85, 86]. Triclosan has been shown to select for multiple antibiotic
resistant P. aeruginosa overpressing the MexCD and MexJK efflux systems
[71, 87], E. coli [15] and Salmonella [9] overexpressing the AcrAB multi-drug
efflux pump and more recently Stenthrophomonas. maltophilia overproducing
the SmeDEF multi-drug efflux pump [88]. Similarily, QAC can select for
resistant S. aureus isolates showing cross resistance to fluoroquinolones as a
13

result of increased norA expression [89] and a modest cross resistance to
several antibiotics as a result of overproduction of MdeA [90]. Exposure to
sub-lethal levels of a QAC disinfectant containing formaldehyde and
glutaraldehyde has also been shown to select for multiple antibiotic resistance
in Salmonella associated with overexpression of AcrAB-tolC [9].
In vivo, the relationship between biocide use and antibiotic resistance is less
clear, with no conclusive evidence being provided to date to suggest that the
observed laboratory phenomena have relevance to the real world [63]. A
recent study reported a lack of correlation between biocide and antibiotic
resistance in bacteria isolated from homes that used or did not use biocide
containing products [91]. Similarly, no correlation was evident between
biocide and antibiotic resistance in a large number of clinical S. aureus and P.
aeruginosa isolates studied over a 10 year period [92]. In contrast, a
comparison of clinical and industrial isolates of P. aeruginosa revealed that
antibiotic/biocide correlations occured with clinical strains only. Studies on
Gram-negative organisms found in urinary tract infections revealed significant
correlations between biocide resistance and multiple antibiotic resistance [93,
94]

4. Physiological impacts associated with biocide resistance-is there a
link?
Studies have shown that when cells encounter a stress, such as the selective
pressure imposed by an antibiotic or a biocide, the cell alters its physiological
status enabling it to survive [80,95]. The precise detail of how different
14
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bacterial cells respond and what occurs at the functional level is currently
incomplete. Nevertheless, it is possible to generalize about some of the
molecular responses (as shown in Figure 5). In the absence of externally
applied stresses, a bacterial cell would be expected to maintain its normal
physiological state (Figure 5 [a]), assuming that appropriate nutrients and
other factors were plentiful. Imposing a particular stress (Figure 5 [b] antibiotic or biocide) causes the cell to transduce this signal into the
cellcytolasm. At a molecular level, one or several genes will respond [24,96].
In some cases expression is switched on (eg: as typified by the chaperones
groEL and others) [97 98], whilst in others gene expression is switched off.
These effects are probably transient and normal status is reinstated once the
stress has disappeared. In contrast, when a different stress is imposed
(Figure 5 [c] –acid) the cell reacts accordingly and yetanother set of genes
display differential regulation patterns. Some of these genes may be common
and react similarly as in the former case. However, at a functional level, the
resulting phenotype may be very different.

Exposure of bacteria originating in animals treated with antibiotics may
provide for a pre-adaptation in some important zoonotic bacteria (including
Salmonella and Campylobacter). The capacity of food-borne bacteria to
survive stresses encountered along the food chain is an important factor
aiding their transmission from animals to humans. Subsequent stressing of
these organisms further along the food chain may serve to increase their
ability to resist any new stresses imposed (combinations of effects outlined in
Figures 5[b] and [c]).
15

The nature of the relationship between antibiotic/biocide resistance and
associated physiological impacts, is only now beginning to be explored. Early
descriptions are at best conflicting. Both antibiotics and biocides can induce
the expression of efflux pumps, but this is likely to be just one of many
responses at the functional level and no clear description has emerged.
Several studies have shown that low level biocide resistance exhibited by
cells results in slower growth rates compared to their isogenic parents [99100]. Similarly, when S. Typhimurium was selected after exposure to
aldehyde, oxidizing and tar-acid based disinfectants, these mutants displayed
reduced growth rates, reduced colony size and were less invasive when cocultured with Caco-2 cells, compared to their isogenic non-selected parent
strains [102, 103]. Karatzas, et al., (2007) also reported that when S.
Typhimurium was selected on a number of commercially applied disinfectants
(including triclosan), mutants recovered had reduced growth rates reduced
invasiveness, as determined using Caco-2 cells [9]. These observations
conflicted with those reported by Webber et al. 2008, showing increased
fitness in Salmonella following selection in triclosan [104].
In E. coli triclosan has been reported to down-regulate some virulence
promoters of outer membrane protein X and p-fimbriae, however these effects
appear to be transient [105]. Starvation and exposure of E. coli O157:H7 to
sodium hypochlorate (such stresses are likely to be encountered by bacteria
in the food production environment) influenced the virulence potential of this
organism. Virulence factors including stx (encoding verocytoxins) and
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attachment components were up-regulated [106]. These contributed to the
survival of this human pathogen.

Conclusions
The advent of multi-drug resistant (MDR) pathogens has created a public
health issue. Recent reports highlight the importance of food as an avenue
for the dissemination of antibiotic resistant genes to humans, thereby reducing
the efficacy of our current arsenal of drugs. To effectively combat this
problem, a comprehensive understanding of the mechanisms involved are
essential. The isolation of antibiotic resistant pathogens from retail food
products, underpins the fact that a potential reservoir of antibiotic resistant
bacteria may exist within the food -chain. It is speculative whether or not,
depending on the genotypes of these organisms, the efficacy of biocides may
be also be compromised.

It is unclear, at present whether a link between antibiotic and biocide
resistance exists in-vivo. Although laboratory data appears to support such a
link, there is a lack of convincing evidence from natural sources, despite the
involvement of some common mechanisms including efflux pumps. However,
all studies agree the prudent use of antimicrobials (antibiotics and biocides) is
important.

17
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In the absence of any new antibiotics, the importance of plasmid-mediated
resistance transfer and efflux pumps, in the development and maintanance of
antibiotic resistance cannot be underestimated. Effective strategies aimed at
plasmid curing and inhibition of efflux pump activity would be legitimate
targets to pursue in the expectation that novel inhibitors could be developed.
Neither compound type has been licensed for use in the treatment of bacterial
infections in human and veterinary medicine. In gaining a better
understanding of these mechanisms, it may be possible in the future to
develop a rationally-based inhibitor(s), based on the kowledge of structurally
vulnerable targets.
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Figure legends
Figure 1: Structure of composite (a), complex (b) transosons and integrons
associated with antibiotic resistance in bacteria.
Figure 2: A schematic representation of the current categorisation of
antimicrobials
Figure 3: Schematic diagram of the main efflux determinants of biocide
resistance in (a) Gram-positive and (b) Gram-negative bacteria
Figure 4: Chemical structure of benzalkonium chloride (QAC’s),
chlorhexidine and triclosan
Figure 5: A general schematic illustrating the responses at a molecular level
in a cell under normal (a), antibiotc/biocide stress (b) and acid stress (c)
conditions.
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